Physician profile
Dhara Ramesh Patel
NPI 1225720865
$2,642.84
in general payments reported to CMS, 2019-2025
17 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what 86% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $272 · 2024: $920 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,334 · Travel and Lodging: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,334.39 |
| Travel and Lodging | $308.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $607.08 | 2024-2025 | Ortholoc 2 Lapifuse, Easyfuse, Citrefix |
| Kerecis Limited | $358.16 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimmer Biomet Holdings, INC. | $323.68 | 2024 | Avitus Bone Harvester, Tapestry, Nextremity General Instrument |
| Amgen INC. | $232.05 | 2024-2025 | Krystexxa |
| Integra Lifesciences Corporation | $149.09 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $148.37 | 2024 | |
| Mimedx Group, INC. | $133.31 | 2024 | |
| Tactile Systems Technology INC | $127.88 | 2025 | Nimbl, Flexitouch Plus |
| Smith+Nephew, INC. | $119.70 | 2023 | Grafix Xc, Stravix Pl, Grafix Pl |
| Globus Medical, INC. | $115.01 | 2025 | Senza |
| Medtronic, INC. | $110.90 | 2025 | Inceptiv |
| Pinnacle, INC | $56.76 | 2024-2025 | |
| Organogenesis INC. | $48.46 | 2025 | Cygnus Matrix, Puraply Wound Matrix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.19 | 2024 | Lifevest |
| Paragon 28, INC. | $34.31 | 2023-2025 | Mtp, Precision Mis Bunion |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $26.78 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $16.11 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhara Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.